Praxis Precision Medicines (PRAX) Cash from Operations Growth (1y) (2020 - 2026)
Praxis Precision Medicines (PRAX) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 158.60% |
| 10 | Praxis Precision Medicines | 9.31 Bn | 8.53 Bn | - | -62.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.52% |
| Dec 31, 2025 | -36.00% |
| Sep 30, 2025 | -136.57% |
| Jun 30, 2025 | -100.44% |
| Mar 31, 2025 | -154.16% |
| Dec 31, 2024 | -135.20% |
| Sep 30, 2024 | -18.46% |
| Jun 30, 2024 | 12.61% |
| Mar 31, 2024 | 36.50% |
| Dec 31, 2023 | 17.17% |
| Sep 30, 2023 | 48.32% |
| Jun 30, 2023 | 45.44% |
| Mar 31, 2023 | 39.30% |
| Dec 31, 2022 | 35.78% |
| Sep 30, 2022 | -87.46% |
| Jun 30, 2022 | -90.61% |
| Mar 31, 2022 | -110.36% |
| Dec 31, 2021 | -121.76% |
| Sep 30, 2021 | -72.61% |
| Jun 30, 2021 | -201.82% |